Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07633197 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Phase I Clinical Trial of Recombinant Herpes Zoster Vaccine (CHO Cell)

StatusEnrolling by Invitation
PhasePhase 1
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
To evaluate the safety and tolerability of different dosages of recombinant zoster vaccine (CHO cell) when administered to adults aged 40 years and older.
Trial Details
NCT Number NCT07633197
Lead Sponsor Changchun BCHT Biotechnology Co.
Conditions
(from sponsor)		 Herpes
Related terms Herpes Simplex
Enrollment 120 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov